[Agranulocytosis induced by captopril after 4 months of treatment].
A case of a patient treated by captopril who developed agranulocytosis and sepsis from pulmonary origin is presented. Shortly, we reviewed the pathogenesis of this complication and highlight the fact that in this patient this adverse reaction to captopril was late.
Fernández Seara
J
J
Servicio de Medicina Interna, Hospital Provincial Santa María Madre, Orense.
Domínguez Alvarez
L M
LM
Rodríguez Pérez
R
R
Pereira Jorge
J A
JA
Rodríguez Canal
A
A
D000380:Agranulocytosis / Q000139:chemically induced*; D002216:Captopril / Q000009:adverse effects*; D003922:Diabetes Mellitus, Type 1 / Q000150:complications; D004198:Disease Susceptibility; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy; D007676:Kidney Failure, Chronic / Q000150:complications; D008297:Male; D008875:Middle Aged; D011014:Pneumonia / Q000209:etiology; D011552:Pseudomonas Infections / Q000209:etiology
D002216:Captopril
Agranulocitosis inducida por captopril tras cuatro meses de tratamiento.